Company News

Envela's Q4 EPS of $0.23 crushed the $0.09 estimate by $0.14 per share, while revenue of $80.5M topped consensus by…

Heartflow posts wider-than-expected Q4 loss of $0.29/share but revenue tops estimates by 5.6%, driving 13% stock surge on growth optimism.

DLocal's Q4 EPS of $0.36 crushed the $0.18 estimate by 96%, while revenue of $337.9M beat consensus and surged 65%…

Micron crushes Q2 estimates with $12.20 EPS vs $8.73 consensus, revenue up 196% YoY to $23.86B as AI memory demand…

Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.

General Mills Q3 EPS of $0.64 missed estimates by 12.1% as strategic pricing investments weighed on results; management reaffirms guidance,…

Star Equity posts Q4 loss of $0.10 per share, missing estimates by 152.6%, despite 69% revenue growth to $56.8M.

Ovid Therapeutics swings to $0.06 EPS profit versus -$0.10 estimate, reversing year-ago loss with $9.7M net income on $700K revenue.

CEO Adam Grossman sold 15,000 shares at $15.16, part of a broader pattern of net insider selling totaling 125,192 shares…

CEO John Gregory Turner forfeited 16,130 shares at $13.60 for tax withholding, part of a six-month pattern showing 582,124 net…